Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXC7XS
|
||||
| Drug Name |
[(S)-1-((S)-3-Benzyloxy-2-oxo-1-phenethyl-propylcarbamoyl)-3-methyl-butyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL100428
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C32H38N2O5
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCc2ccccc2)C(=O)COCc3ccccc3
|
||||
| InChI |
InChI=1S/C32H38N2O5/c1-24(2)20-29(34-32(37)39-22-27-16-10-5-11-17-27)31(36)33-28(19-18-25-12-6-3-7-13-25)30(35)23-38-21-26-14-8-4-9-15-26/h3-17,24,28-29H,18-23H2,1-2H3,(H,33,36)(H,34,37)/t28-,29-/m0/s1
|
||||
| InChIKey |
IZYFXHSVFKJFOS-VMPREFPWSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.